Medical and Science
APPA announces 2020 executive committee
The Australian Pharmaceutical medical and scientific Professionals Association (APPA) is pleased to announce the recently elected Executive Committee Members for 2020.
APPA is the representative association for Medical Affairs in Australia and is dedicated to promoting excellence in pharmaceutical medicine through professional development, networking and advocacy.
The association encompasses medical directors, medical advisors and medical scientific liaisons working within medical affairs departments of Australian pharmaceutical companies.
Dr. Gisela Mautner (current Vice President of APPA) was elected as the new President for 2020.
“My vision is to continue to build on our achievements of the last few years but also start new collaborations and partnerships to increase APPA’s visibility and its relevance in shaping Medical Affairs.” said Dr Mautner.
APPA Executive Committee Members for 2020
President: Dr. Gisela Mautner
Past President: Dr. Paul Theron – Merck Group
Vice President: Matthew Britland – AstraZeneca
Treasurer: Dr. Martin Rees – Stallergenes Greer
Secretary: Dr. David Grolman – Pfizer
Ordinary Members:
- Lauren Kennedy – AbbVie
- Bevan Sweerts – Sanofi Genzyme
- Mauricio Andrade – Pfizer
Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.
Digital & Innovation
Cybersecurity tops investment priorities for ANZ companies
Digital & Innovation: Cybersecurity remains the top technology investment for Australian and New Zealand (ANZ) companies, with a striking 88% […]
MoreNews & Trends - Pharmaceuticals
Novo Nordisk and Lilly’s GLP-1 agonists show promise in type 1 diabetes
Pharma News: GLP-1 receptor agonists lead to significant weight loss and improve blood sugar control in individuals with type 1 […]
MoreNews & Trends - MedTech & Diagnostics
Health Department’s proposed reporting rules face industry pushback over costs and confidentiality
MedTech News: The Department of Health has unveiled stakeholder feedback on the reporting requirements for the Prescribed List (PL), sparking […]
MoreNews & Trends - MedTech & Diagnostics
Threat to innovation: Health Department’s PL reforms spark industry backlash
MedTech News: The Department of Health has unveiled stakeholder feedback on the alignment of charges for supplying medical devices with […]
More